Letter to the Editor regarding "Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?".
作者信息
Fernandes Timothy M, Papamatheakis Demosthenes G, Poch David S, Kim Nick H
机构信息
Division of Pulmonary and Critical Care Medicine, Section of Pulmonary Vascular Medicine, University of California, San Diego, USA.
出版信息
Pulm Circ. 2020 May 14;10(2):2045894020925761. doi: 10.1177/2045894020925761. eCollection 2020 Apr-Jun.
Abstract
摘要
相似文献
1
Letter to the Editor regarding "Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?".致编辑的信：关于“肺动脉高压患者感染重症 COVID-19 的风险是否较低？”
Pulm Circ. 2020 May 14;10(2):2045894020925761. doi: 10.1177/2045894020925761. eCollection 2020 Apr-Jun.
2
Author rebuttal to response regarding "Letter to the Editor regarding 'Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?'".作者对关于“致编辑的信：肺动脉高压患者感染重症 COVID-19 的风险是否较低？”的回复的反驳。
Pulm Circ. 2020 Jun 23;10(3):2045894020936663. doi: 10.1177/2045894020936663. eCollection 2020 Jul-Sep.
3
Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor.肺动脉血栓形成作为新型冠状病毒肺炎肺部疾病的重要并发症：致编辑的信
Virchows Arch. 2020 Sep;477(3):467-468. doi: 10.1007/s00428-020-02896-4.
4
Letter to editor: Mortality in pulmonary arterial hypertension due to congenital heart disease: Serial changes improve prognostication.致编辑的信：先天性心脏病所致肺动脉高压的死亡率：系列变化改善预后评估。
Int J Cardiol. 2018 Mar 1;254:302. doi: 10.1016/j.ijcard.2017.06.096. Epub 2018 Jan 28.
5
Letter to Editor: Prevalence and Determinants of Delay in Time-to-Diagnosis for Pulmonary Arterial Hypertension (PAH) Patients in Gansu China: An Observational Cohort Study.
Curr Probl Cardiol. 2024 Feb;49(2):102133. doi: 10.1016/j.cpcardiol.2023.102133. Epub 2023 Oct 16.
6
Reply to Letter to the Editor - Targeted Treatments for Pulmonary Arterial Hypertension: Interpreting Outcomes by Network Meta-Analysis.致编辑的信的回复——肺动脉高压的靶向治疗：通过网络荟萃分析解读结果
Heart Lung Circ. 2016 Nov;25(11):1139. doi: 10.1016/j.hlc.2016.06.1203. Epub 2016 Jul 19.
7
Isoprostane as a promising biomarker in pulmonary arterial hypertension: preanalytical and analytical viewpoints. Response to letter to the editor.
Int J Cardiol. 2014 Dec 15;177(2):632-3. doi: 10.1016/j.ijcard.2014.09.122. Epub 2014 Oct 2.
8
The course of COVID-19 in a 55-year-old patient diagnosed with severe idiopathic pulmonary arterial hypertension.一名55岁被诊断为重度特发性肺动脉高压患者的新冠肺炎病程。
Pulm Circ. 2020 Jul 28;10(3):2045894020936659. doi: 10.1177/2045894020936659. eCollection 2020 Jul-Sep.
9
Reply to letter to editor: Association between pulmonary arterial obstruction index and right lateral ventricular wall thickness with in-hospital mortality in patients with acute pulmonary embolism.致编辑的信的回复：急性肺栓塞患者肺动脉阻塞指数与右心室侧壁厚度与院内死亡率之间的关联
Emerg Radiol. 2021 Aug;28(4):865. doi: 10.1007/s10140-021-01917-2. Epub 2021 Feb 13.
10
Reply to letter to the editor "infections by gram-negative bacilli in patients with pulmonary arterial hypertension treated with intravenous prostacyclin".
Arch Bronconeumol. 2013 May;49(5):217-8. doi: 10.1016/j.arbres.2012.10.002. Epub 2012 Dec 4.
引用本文的文献
1
Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry.2019年冠状病毒病大流行对肺动脉高压患者慢性病管理及患者报告结局的影响：肺动脉高压协会注册研究
Pulm Circ. 2023 Apr 1;13(2):e12233. doi: 10.1002/pul2.12233. eCollection 2023 Apr.
2
Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome.肺血管稳态和急性呼吸窘迫综合征中的内皮代谢。
Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L358-L376. doi: 10.1152/ajplung.00131.2021. Epub 2021 Jun 23.
3
COVID-19 in Pulmonary Artery Hypertension (PAH) Patients: Observations from a Large PAH Center in New York City.肺动脉高压（PAH）患者中的新型冠状病毒肺炎（COVID-19）：来自纽约市一家大型PAH中心的观察结果
Diagnostics (Basel). 2021 Jan 15;11(1):128. doi: 10.3390/diagnostics11010128.
4
Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.在 COVID-19 大流行和远程医疗革命时代的肺动脉高压患者的风险评估：最新综述。
J Heart Lung Transplant. 2021 Mar;40(3):172-182. doi: 10.1016/j.healun.2020.12.005. Epub 2020 Dec 19.
5
COVID-19 and Pulmonary Arterial Hypertension: Early Data and Many Questions.新型冠状病毒肺炎与肺动脉高压：早期数据及诸多问题
Ann Am Thorac Soc. 2020 Dec;17(12):1528-1530. doi: 10.1513/AnnalsATS.202008-1014ED.
6
Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.新型冠状病毒诱导的急性呼吸窘迫综合征（ARDS）中肺血管收缩的新兴机制和潜在治疗靶点。
Int J Mol Sci. 2020 Oct 29;21(21):8081. doi: 10.3390/ijms21218081.
7
Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.2019年冠状病毒病大流行期间肺动脉高压的右心导管检查
Pulm Circ. 2020 Sep 16;10(3):2045894020948783. doi: 10.1177/2045894020948783. eCollection 2020 Jul-Sep.
8
Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension.2019冠状病毒病对肺循环的影响。毛细血管前性肺动脉高压的特殊情况。
Diagnostics (Basel). 2020 Jul 31;10(8):548. doi: 10.3390/diagnostics10080548.
9
Author rebuttal to response regarding "Letter to the Editor regarding 'Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?'".作者对关于“致编辑的信：肺动脉高压患者感染重症 COVID-19 的风险是否较低？”的回复的反驳。
Pulm Circ. 2020 Jun 23;10(3):2045894020936663. doi: 10.1177/2045894020936663. eCollection 2020 Jul-Sep.
本文引用的文献
1
Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?肺动脉高压患者患重症 COVID-19 的风险会更低吗？
Pulm Circ. 2020 Apr 27;10(2):2045894020922799. doi: 10.1177/2045894020922799. eCollection 2020 Apr-Jun.
2
Coronavirus Disease 2019 (COVID-19) in Italy.意大利的2019冠状病毒病（COVID-19）。
JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344.
3
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
4
Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.西地那非对慢性阻塞性肺疾病合并肺动脉高压患者血流动力学和气体交换的影响。
Am J Respir Crit Care Med. 2010 Feb 1;181(3):270-8. doi: 10.1164/rccm.200907-0988OC. Epub 2009 Oct 29.
Zotero 插件